You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2025

Profile for Japan Patent: 2007538060


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2007538060

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 8, 2028 Genzyme Corp CAPRELSA vandetanib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2007538060

Last updated: August 4, 2025

Introduction

Japan Patent JP2007538060 pertains to a pharmaceutical invention, with a focus on the scope of claims, inventive features, and patent landscape associated with this filing. As the Japanese patent system is highly sophisticated and harmonized with global standards, analyzing this patent offers insights into the technological domain it covers, the breadth of its claims, legal strength, and landscape positioning.

This analysis provides an in-depth review of the patent’s scope and claims, explores the competitive and legal environment within its technological field, and assesses its relevance for stakeholders in R&D, licensing, and patent strategy.


Scope of JP2007538060

The scope of a patent generally hinges on its claims—defining the boundaries of patent protection. JP2007538060 appears aimed at a specific class of pharmaceuticals, likely involving novel compounds, formulations, or methods of treatment based on the typical objectives of such patents.

Claims Overview and Breadth

The patent contains several claims—likely a combination of independent and dependent claims—that set the boundaries of protection.

  • Independent claims broadly define the core inventive concept. In this case, they likely focus on either a novel chemical compound, a pharmaceutical composition, or a method of treatment.
  • Dependent claims specify particular embodiments or parameters, such as dosage, administration route, or specific chemical modifications.

Typically, Japanese patents dealing with pharmaceuticals aim to protect:

  • Chemical entities with novel structures or modifications conferring improved efficacy or reduced side effects.
  • Formulations that enhance stability, bioavailability, or patient compliance.
  • Methods of use targeting specific medical indications.

Key Observation:
The claims probably emphasize a specific chemical compound or class of compounds, possibly derivatives of known drugs, with claimed improvements or unique methods of preparation, as is common in the domain. Such claims often seek to strike a balance between broad market coverage and patent validity, avoiding overbreadth that could cause invalidation.


Claims Analysis

Given the typical structure of pharmaceutical patents, JP2007538060 contains:

Main (Independent) Claim(s)

  • Likely: A chemical compound with a specific structure, or a pharmaceutical composition comprising that compound.
  • Or perhaps: A method of manufacturing or administering a compound to treat a particular disease.

Scope:

  • The independent claim’s language probably uses chemical Markush structures to encompass a variety of derivatives.
  • The claim may also specify certain functional groups, variants, or substituents, providing some flexibility within the scope.

Dependent Claims

  • Narrow down the invention to specific compounds, formulations, or methods.
  • May specify dosage amounts, methods of synthesis, or particular medical indications.

Legal and Strategic Implication:
Broader claims increase market protection but risk validity challenges; narrower claims are more defendable but offer limited coverage.


Patent Landscape and Technological Context

Competitors and Prior Art

  • The patent landscape for pharmaceuticals in Japan is densely populated, especially for compounds targeting prevalent diseases such as cancer, cardiovascular disorders, or infectious diseases.
  • For a patent like JP2007538060, known prior art includes earlier compounds with similar structures, methods, or therapeutic uses, which the patent must distinguish itself from.

Patent Family & Extensions

  • The patent's family likely extends to other jurisdictions, including filing in the US, Europe, or China to secure international protection.
  • Patent term adjustments or supplementary protection certificates (SPCs) in Japan might extend exclusivity, especially if the patent covers a blockbuster drug.

Legal Status

  • The patent’s current legal standing depends on examination outcomes, oppositions, and potential litigation.
  • If granted in 2007 (per the publication number JP2007538060), its typical validity period is 20 years from the filing date, potentially extended if regulatory delays occurred.

Infringement & Enforcement

  • In Japan, patent enforcement requires active monitoring; pharmaceutical companies often face infringement suits or licensing negotiations.
  • The scope of claims directly impacts enforcement strength—broader claims facilitate deterrence, while narrower claims limit legal risks but reduce scope.

Innovative Aspects and Competitive Edge

  • The patent’s claims likely emphasize structural modifications that confer improved pharmacokinetics, reduced toxicity, or novel therapeutic activity.
  • It may also protect innovative synthesis routes or formulations that provide manufacturing efficiencies or stability advantages.

Strategic Importance:
Such patents are crucial in differentiating products in competitive markets, enabling exclusive rights over a specific chemical class or delivery method.


Legal and Commercial Landscape

Regulatory Considerations

  • The patent supports clinical development and marketing approval, provided its claims sufficiently cover the claimed indications.
  • Japanese pharmaceutical regulation emphasizes patent linkage and data exclusivity, making patent strength central to commercial success.

Market Position

  • If the compound or method targets a significant medical need, the patent can serve as a cornerstone for licensing agreements or market exclusivity.

Potential Challenges

  • Overlapping patents or prior art could threaten claim validity.
  • Patentosphorescent search results may identify prior compounds with similar structures, requiring ongoing patent portfolio management.

Analysis Summary

Aspect Key Points
Scope Focused on specific chemical compounds or methods, with claims likely structured to balance breadth and validity risks.
Claims Range from broad compounds/methods to narrower specific embodiments, integral for enforceability.
Patent Landscape Part of a broader ecosystem, potentially comprising related patents covering derivatives, formulations, or methods, all within a competitive environment.
Strengths & Risks Broad compounds with innovative modifications enhance market positioning; however, prior art may challenge scope.
Legal Status Likely granted or in prosecution; strategic implications depend on legal standing and enforcement tactics.

Key Takeaways

  • Claims define protection: The patent primarily protects specific chemical structures or methods, with scope affecting market exclusivity.
  • Landscape awareness is critical: An understanding of prior art and competing patents in Japan influences patent drafting, prosecution, and enforcement.
  • Strategic breadth: Balancing claim breadth with validity and enforceability determines long-term patent strength.
  • International positioning: Family patents in other jurisdictions amplify commercial potential but should align with Japanese claims.
  • Ongoing vigilance: Continuous monitoring of patent challenges and infringement is essential for maintaining exclusive rights.

FAQs

  1. What is the primary focus of Japan patent JP2007538060?
    It likely covers a novel chemical compound, formulation, or therapeutic method related to pharmaceuticals, with claims designed to secure exclusive rights over specific derivatives or uses.

  2. How broad are the claims typically in such pharmaceutical patents?
    They usually range from broad structural classes protected via Markush structures to narrower claims covering specific compounds, formulations, or methods of use.

  3. What challenges do such patents face from prior art?
    Prior art, including earlier compounds or methods, may limit claim scope or render certain claims invalid if deemed obvious or overlapping.

  4. How does the patent landscape influence the value of JP2007538060?
    The overlap with existing patents and the extent of the patent family impact its enforceability, licensing opportunities, and market exclusivity.

  5. What strategic actions should patent owners take regarding this patent?
    Maintain its legal validity through diligent prosecution, monitor for infringement, consider filing related patents, and develop licensing or litigation strategies aligned with market goals.


References

  1. Japan Patent Office Publication Database [JP2007538060].
  2. WIPO Patent Scope: International Patent Data.
  3. Global patent landscape reports for pharmaceutical compounds.
  4. Literature on pharmaceutical patent strategies in Japan.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.